NCT06819865 A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
| NCT ID | NCT06819865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Scientific Corporation |
| Condition | Acute Pulmonary Embolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-08-30 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-08-30 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Eligibility Criteria
Inclusion Criteria: 1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days). 2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image 3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient. Exclusion Criteria: 1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days). 2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image 3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Contact & Investigator
Cheng Hong, Doctor
PRINCIPAL INVESTIGATOR
The First Affiliated Hospital of Guangzhou Medical University
Frequently Asked Questions
Who can join the NCT06819865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Pulmonary Embolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06819865 currently recruiting?
Yes, NCT06819865 is actively recruiting participants. Contact the research team at changgq@mail.sysu.edu.cn for enrollment information.
Where is the NCT06819865 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06819865 clinical trial?
NCT06819865 is sponsored by Boston Scientific Corporation. The principal investigator is Cheng Hong, Doctor at The First Affiliated Hospital of Guangzhou Medical University. The trial plans to enroll 30 participants.